<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://gcig-occc2021.digi-event.be/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://gcig-occc2021.digi-event.be/topic/general-discussion/</loc><lastmod>2021-10-06T20:40:06+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/general-discussion-2/</loc><lastmod>2021-10-06T20:40:35+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/general-discussion-3/</loc><lastmod>2021-10-06T20:40:45+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/general-discussion-4/</loc><lastmod>2021-10-06T20:40:52+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/role-of-dose-dense-regimens/</loc><lastmod>2021-10-12T12:52:10+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/to-do-or-not-to-do-interval-debulking-in-nact-patients/</loc><lastmod>2021-10-16T11:48:54+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/minimally-invasive-surgery-vs-laparotomy/</loc><lastmod>2021-10-16T11:53:05+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/number-of-nact/</loc><lastmod>2021-10-16T11:56:19+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/biomarkers-as-stratification-factors/</loc><lastmod>2021-10-16T11:58:42+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/mdt/</loc><lastmod>2021-10-16T11:59:12+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/crs/</loc><lastmod>2021-10-16T12:02:02+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/early-stage-tumours/</loc><lastmod>2021-10-16T14:04:36+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/early-stage-cancer-studies/</loc><lastmod>2021-10-16T14:13:33+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/maintenance-and-hrql/</loc><lastmod>2021-10-16T14:28:59+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/hipec-ip/</loc><lastmod>2021-10-16T16:51:28+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/bevacizumab-vs-parpi/</loc><lastmod>2021-10-17T12:00:01+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/control-arm-discussion/</loc><lastmod>2021-10-17T12:01:17+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/maintenance-in-the-reference-arm-in-the-recurrent-setting/</loc><lastmod>2021-10-17T12:02:20+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/secondary-cytoreduction-discussion/</loc><lastmod>2021-10-17T12:29:13+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/ago-imodel-reporting/</loc><lastmod>2021-10-17T12:32:23+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/active-palliative-care-in-plat-refractory-patients/</loc><lastmod>2021-10-17T13:11:46+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/germ-cell-tumours-chemotherapy-control-arms-number-of-cycles/</loc><lastmod>2021-10-18T12:53:03+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/control-sact-arm-for-relapsed-ogct-and-nomenclature-in-that-statement/</loc><lastmod>2021-10-18T13:35:02+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/frailty-index/</loc><lastmod>2021-10-18T14:26:55+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/under-represented-groups/</loc><lastmod>2021-10-18T14:32:27+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/secondary-endpoint/</loc><lastmod>2021-10-19T12:23:19+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/harmonized-dcr-definition/</loc><lastmod>2021-10-19T13:04:01+00:00</lastmod></url><url><loc>https://gcig-occc2021.digi-event.be/topic/harmonized-dcr-definition-2/</loc><lastmod>2021-10-19T13:05:12+00:00</lastmod></url></urlset>
